Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Biofrontera Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BFRI
Nasdaq
2834
https://www.biofrontera-us.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Biofrontera Inc
Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
- Mar 26th, 2024 8:30 pm
Biofrontera Inc. (NASDAQ:BFRI) Q4 2023 Earnings Call Transcript
- Mar 19th, 2024 1:22 pm
Q4 2023 Biofrontera Inc Earnings Call
- Mar 19th, 2024 5:57 am
CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
- Mar 16th, 2024 12:25 am
Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
- Mar 15th, 2024 10:10 pm
Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024
- Mar 8th, 2024 1:00 pm
Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules
- Feb 23rd, 2024 1:40 pm
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
- Feb 20th, 2024 1:10 pm
Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules
- Feb 20th, 2024 1:05 pm
Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use
- Feb 5th, 2024 10:15 pm
Biofrontera Inc. (NASDAQ:BFRI): Is Breakeven Near?
- Jan 31st, 2024 12:11 pm
Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2023
- Jan 11th, 2024 9:15 pm
Biofrontera Inc. (BFRI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
- Nov 22nd, 2023 2:55 pm
Biofrontera Inc. (NASDAQ:BFRI) Q3 2023 Earnings Call Transcript
- Nov 11th, 2023 5:05 pm
Benign Growth For Biofrontera Inc. (NASDAQ:BFRI) Underpins Stock's 50% Plummet
- Nov 11th, 2023 12:07 pm
Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business Update
- Nov 9th, 2023 10:10 pm
Biofrontera Inc. (BFRI) Upgraded to Buy: Here's What You Should Know
- Nov 9th, 2023 5:00 pm
Biofrontera Inc. to Report Third Quarter 2023 Financial Results on November 9 and Hold Conference Call on November 10
- Nov 3rd, 2023 12:30 pm
Biofrontera Inc. Announces $4.5 Million Registered Direct Offering Priced At-the-market Under NASDAQ Rules
- Oct 31st, 2023 12:01 pm
Biofrontera Inc. Receives FDA Approval for New Formulation of Ameluz(R)
- Oct 10th, 2023 1:00 pm
Scroll